Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
Newer Targets
Novel discovery in gene therapy to treat kidney diseases …
Newer Targets
Stanford researchers program cancer-fighting cells to resist exhaustion, attack solid tumors…
Newer Targets
Dyno Therapeutics Announces Research Published in Science Enabling Artificial Intelligence Approach…
Newer Targets
Hepion Pharmaceuticals’ CRV431 Prevents Cirrhosis in Experimental Model of Severe Liver…
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Clinical
FDA Committee Votes 6-6 on Durect’s Non-Opioid Pain Drug
Approval
Novo Nordisk’s Ozempic Wins Approval for Reducing Cardiovascular Events in Diabetes…
Clinical
FDA advisory panel split on whether to approve Durect’s Posimir for…
Approval
Breast cancer patients to have further NICE-approved drug combination option on…
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Deals
Seneca Biopharma Surges Near 113% After Comments on Seeking Partnership for…
Deals
TB Alliance Announces Partnership with Hongqi Pharma to Commercialize New Therapy…
Commercial
US judge hacks $8-billion damages verdict against Johnson & Johnson in…
Deals
JPM Day 3: High Prices in San Francisco Are a Problem,…
Home
Clinical
Launch
Launch
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Launch
Grifols to launch TAVLESSE in Europe and Turkey to continue reinforcing its commercial strategy and commitment to patients
Firstwordpharma News
-
January 16, 2020
Launch
INTELLiSTEM Announces the Launch of a New Antigen Identification Platform for the Development of Novel Car T Cells
Launch
bluebird bio Announces Launch in Germany of ZYNTEGLO (autologous CD34+ cells encoding ?A-T87Q-globin gene) Gene Therapy for Patients 12 Years and Older with Transfusion-Dependent...
Launch
Demands for Solutions to Challenging Diseases Prompts Launch of Azymus Therapeutics Inc.
Launch
ANI Announces Launch of Paliperidone Extended-Release Tablets
Launch
Eli Lilly to launch two more authorised Humalog generic products in...
Firstwordpharma News
-
January 14, 2020
0
Launch
TIO Bioventures Launches Treadwell Therapeutics, Seeded With $27m to Develop First-in-Class...
Firstwordpharma News
-
January 13, 2020
0
Launch
Genetown Startup Launches with $200 Million and Mission to Develop Affordable...
Biospace News
-
January 13, 2020
0
Launch
On Heels of the Sale of Five Vants, Roivant Launches New...
Biospace News
-
January 13, 2020
0
Launch
Bio-Thera Solutions Launches First Commercial Product, QLETLI, in China
Firstwordpharma News
-
January 10, 2020
0
1
2
3
...
14
Page 1 of 14
- Advertisement -
MOST POPULAR
Legal Battle Over Between ‘Pharma Bro’ Martin Shkreli and Retrophin
June 21, 2019
Hoth Therapeutics to Present at the 9th Annual LD Micro Invitational...
May 29, 2019
COPD Market Expected to Grow as Number of Cases Continues Rising
November 27, 2019
Tarus Therapeutics, Inc., acquires license to Adenosine Receptor Antagonist Platform from...
December 23, 2019
Load more
HOT NEWS
Commercial
Algiax Pharmaceuticals Announces New Executive Team and Clinical Trial Plan for...
Others
Sobi Strengthens Focus and Increases Investments in Late-Stage Development in Haematology...
Deals
OSE Immunotherapeutics Announces Licensing Deal for Neoepitope Combination Tedopi in Korea...
Phase I
Ascentage Pharma announces first patient dosed in Phase I clinical trial...
